269 related articles for article (PubMed ID: 29560517)
1. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
[TBL] [Abstract][Full Text] [Related]
2. Cartilage oligomeric matrix protein (COMP) promotes cell proliferation in early-onset colon cancer tumorigenesis.
Nfonsam VN; Jecius HC; Janda J; Omesiete PN; Elquza E; Scott AJ; Nfonsam LE; Jandova J
Surg Endosc; 2020 Sep; 34(9):3992-3998. PubMed ID: 31617091
[TBL] [Abstract][Full Text] [Related]
3. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
4. Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology.
Nfonsam VN; Jecius H; Chen D; Omesiete PN; Ewongwo AN; Elquza E; Scott AJ; Jandova J
J Am Coll Surg; 2019 Jul; 229(1):79-90. PubMed ID: 30995524
[TBL] [Abstract][Full Text] [Related]
5. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
8. PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.
Li F; Zhang C; Fu L
PLoS One; 2019; 14(10):e0218839. PubMed ID: 31596887
[TBL] [Abstract][Full Text] [Related]
9. Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway.
Li XX; Huang LY; Peng JJ; Liang L; Shi DB; Zheng HT; Cai SJ
Int J Oncol; 2014 Aug; 45(2):611-8. PubMed ID: 24818842
[TBL] [Abstract][Full Text] [Related]
10. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
Lei Y; Wang YH; Wang XF; Bai J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.
Wu Z; Cui F; Yu F; Peng X; Jiang T; Chen D; Lu S; Tang H; Peng Z
Biochem Biophys Res Commun; 2014 Jun; 449(2):208-15. PubMed ID: 24845563
[TBL] [Abstract][Full Text] [Related]
12. Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival.
Wusterbarth E; Chen Y; Jecius H; Krall E; Runyan RB; Pandey R; Nfonsam V
J Surg Res; 2022 Feb; 270():169-177. PubMed ID: 34687957
[TBL] [Abstract][Full Text] [Related]
13. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
14. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.
Englund E; Bartoschek M; Reitsma B; Jacobsson L; Escudero-Esparza A; Orimo A; Leandersson K; Hagerling C; Aspberg A; Storm P; Okroj M; Mulder H; Jirström K; Pietras K; Blom AM
Oncogene; 2016 Oct; 35(43):5585-5596. PubMed ID: 27065333
[TBL] [Abstract][Full Text] [Related]
15. Impact of
Ma WR; Xu P; Liu ZJ; Zhou J; Gu LK; Zhang J; Deng DJ
World J Gastroenterol; 2020 Jan; 26(2):184-198. PubMed ID: 31988584
[TBL] [Abstract][Full Text] [Related]
16. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients.
Nfonsam VN; Nfonsam LE; Chen D; Omesiete PN; Cruz A; Runyan RB; Jandova J
J Surg Res; 2019 Jan; 233():297-303. PubMed ID: 30502262
[TBL] [Abstract][Full Text] [Related]
17. KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.
Chen EC; Karl TA; Kalisky T; Gupta SK; O'Brien CA; Longacre TA; van de Rijn M; Quake SR; Clarke MF; Rothenberg ME
Gastroenterology; 2015 Sep; 149(3):705-17.e2. PubMed ID: 26026391
[TBL] [Abstract][Full Text] [Related]
18. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.
Shimozato O; Waraya M; Nakashima K; Souda H; Takiguchi N; Yamamoto H; Takenobu H; Uehara H; Ikeda E; Matsushita S; Kubo N; Nakagawara A; Ozaki T; Kamijo T
Oncogene; 2015 Apr; 34(15):1949-60. PubMed ID: 24882578
[TBL] [Abstract][Full Text] [Related]
19. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression.
Yang Y; Li L; He H; Shi M; He L; Liang S; Qi J; Chen W
Exp Cell Res; 2022 Feb; 411(2):113004. PubMed ID: 34990618
[TBL] [Abstract][Full Text] [Related]
20. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]